Home

Alkem Laboratories Ltd PE Ratio

Image

Alkem Laboratories Ltd

NSE: ALKEM

PE

29.5

Last updated on: Jan 13, 2025

Key Highlights

  • The P/E Ratio of Alkem Laboratories Ltd is 29.5 as of 13 Jan 15:09 PM .
  • The P/E Ratio of Alkem Laboratories Ltd changed from 24.7 on March 2020 to 32.9 on March 2024 . This represents a CAGR of 5.90% over 5 years.
  • The Latest Trading Price of Alkem Laboratories Ltd is ₹ 5249 as of 13 Jan 15:03 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Alkem Laboratories Ltd

No data available

Company Fundamentals for Alkem Laboratories Ltd

Image

Alkem Laboratories Ltd

NSE: ALKEM

Share Price

₹ 5249.7

-122.80 (-2.29%)

stock direction

Last updated on: Jan 13, 2025

Market Price of Alkem Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Alkem Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
10 Jan 20255372.5
09 Jan 20255448.15
08 Jan 20255561
07 Jan 20255571.55
06 Jan 20255524.45
03 Jan 20255500.05
02 Jan 20255584.85
01 Jan 20255573.7
31 Dec 20245635.9
30 Dec 20245563.9

SWOT Analysis Of Alkem Laboratories Ltd

Strength

3

che

Weakness

3

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Alkem Laboratories Ltd

Asset Value vs Market Value of Alkem Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Alkem Laboratories Ltd64236
Sun Pharmaceuticals Industries Ltd428533
Divis Laboratories Ltd153076
Cipla Ltd118723
Dr Reddys Laboratories Ltd112998

PE Ratio of Alkem Laboratories Ltd Explained

``

64236

Market cap

2122

Earnings

29.5X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Alkem Laboratories Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Alkem Laboratories Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Alkem Laboratories Ltd

No data available

* All values are in %

About Alkem Laboratories Ltd

  • Headquartered in Mumbai, India, Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations.
  • The company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.
  • The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and international markets.
  • With a portfolio of more than 800 brands in India, Alkem is ranked the fifth largest pharmaceutical company in India in terms of domestic sales.
  • The company also has presence in more than 40 international markets, with the United States being its key focus market. Alkem Laboratories Ltd was incorporated as a private limited company on August 8, 1973 at Patna under the Companies Act, 1956 and subsequently became a deemed public limited company under section 43A(2) of Companies Act, 1956 on October 26, 1988.

Alkem Laboratories Ltd News Hub

Alkem Labs PAT soars 90% YoY to Rs 545 crore in Q1

Revenue from operations stood at Rs 3,031.82 crore in June 2024 quarter, registering a growth of 2.1

Read more

2024-08-09 00:00:00

Alkem Laboratories consolidated net profit rises 90.13% in the June 2024 quarter

Net profit of Alkem Laboratories rose 90.13% to Rs 545.16 crore in the quarter ended June 2024 as ag

Read more

2024-08-09 00:00:00

Alkem Laboratories Ltd soars 3.33%, rises for fifth straight session

Alkem Laboratories Ltd rose for a fifth straight session today. The stock is quoting at Rs 5695.7, u

Read more

2024-08-08 00:00:00

Alkem Laboratories Ltd rises for third consecutive session

Alkem Laboratories Ltd gained for a third straight session today. The stock is quoting at Rs 5407.35

Read more

2024-08-06 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Alkem Laboratories Ltd

What is the current PE Ratio of Alkem Laboratories Ltd?

The Current PE Ratio of Alkem Laboratories Ltd is 29.54 as on 13 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 13 Jan 2025.

What was the PE Ratio of Alkem Laboratories Ltd last year?

The PE Ratio of Alkem Laboratories Ltd was 41.28 last year, now the PE ratio is 29.54, showing a year-on-year growth of -28.4%.

What does the PE Ratio of Alkem Laboratories Ltd indicate about its stock?

The PE Ratio of Alkem Laboratories Ltd is 29.54. This ratio indicates that investors are willing to pay 29.54 times the earnings per share for each share of Alkem Laboratories Ltd.

What is the PE Ratio Growth of Alkem Laboratories Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Alkem Laboratories Ltd grew by -28.4% whereas, the EPS ratio grew by 26.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions